JEMO-PHARM A/S: Financial statements 2021
CVR: 10216109
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 11,517,000 and a net result of DKK 166,000 compared with DKK -2,809,000 the year before. That is an increase of 33.8% compared with the year before. Equity in the 2021 report amounted to DKK 566,000. The solvency ratio was 1.4%. The company had 28 employees in the financial year.
- Gross Profit
- DKK 11,517,000
- Profit/Loss
- DKK 166,000
- Equity
- DKK 566,000
- Total Assets
- DKK 41,053,000
- Employees
- 28
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 11.5 mio. | 166 t. | 566 t. | 28 |
| 2020 | - | 8.6 mio. | -2.8 mio. | 400 t. | 24 |
| 2019 | - | 5.9 mio. | -6.1 mio. | -3.5 mio. | 25 |
| 2018 | - | 9.8 mio. | 23 t. | 2.6 mio. | 20 |
| 2017 | - | 9 mio. | 522 t. | 2.5 mio. | 17 |
Official annual report
Find more companies like JEMO-PHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
JEMO-PHARM A/S has published its annual report for 2020. Gross profit came to DKK 8,608,000, and the net result was DKK -2,809,000.
As of January 20, 2021, Erik Valentin Harby has joined the board of directors of JEMO-PHARM A/S.
As of January 20, 2021, Mikael Andreas Mohr has joined the board of directors of JEMO-PHARM A/S.
As of January 20, 2021, Niels Ulrik Svendsen has left the board of directors of JEMO-PHARM A/S.
As of January 20, 2021, Mark Ole Juel Hemmingsen has left the board of directors of JEMO-PHARM A/S.
As of January 20, 2021, Mikael Andreas Mohr is registered as director of JEMO-PHARM A/S.
As of January 20, 2021, Henrik Winther Olsen has stepped down as director of JEMO-PHARM A/S.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.